Starting from tomorrow, the screening of newborn genetic metabolic diseases in Shanghai will increase from 4 to 15 types.
In order to further implement active fertility support measures, strengthen the screening and diagnosis of genetic and metabolic diseases in newborns in this city, and improve the level of prenatal and postnatal care services, starting from June 1, Shanghai will divide the screening categories for genetic and metabolic diseases in newborns in this city into four types. Increased to 15 types.
The Municipal Health Commission issued the "Shanghai Management Measures for the Screening of Neonatal Inherited Metabolic Diseases". According to the management measures, this city has the following conditions: congenital hypothyroidism, phenylketonuria, congenital adrenal hyperplasia and glucose- On the basis of screening for the four diseases of 6-phosphate dehydrogenase deficiency, methylmalonic acidemia, primary carnitine deficiency, hitrin protein deficiency, and medium-chain acyl-CoA dehydrogenase deficiency are added. , propionic acidemia, isovaleric acidemia, glutaric acidemia type Ⅰ, maple syndrome, very long chain acyl-CoA dehydrogenase deficiency, citrullinemia type Ⅰ and homocystinemia Screening for 11 diseases of type Ⅰ.
In order to cooperate with this work, the Municipal Medical Insurance Bureau, the Municipal Development and Reform Commission, the Municipal Finance Bureau, and the Municipal Health Commission jointly issued the "Notice on Issues Concerning Adjustments to the Municipal Fertility Medical Expenses Subsidy Standards" starting from June 1 this year. , increase the subsidy for maternity medical expenses from 4,200 yuan to 4,500 yuan, including the subsidy for maternity medical expenses for critically ill pregnant women from 8,000 yuan to 8,300 yuan.
It is understood that Shanghai has taken the lead in carrying out newborn phenylketonuria screening in the country since the early 1980s. In 2007, in addition to the nationally prescribed screening for congenital hypothyroidism and phenylketonuria, screening for congenital adrenal hyperplasia and glucose-6-phosphate dehydrogenase deficiency was added. In 2023, the city’s newborn screening rate for genetic metabolic diseases will be 99.6%. Over the past 40 years, the city has built a screening service and management network covering community health service centers, midwifery medical institutions, maternal and child health care institutions, critically ill newborn consultation and rescue centers, and newborn genetic metabolic disease screening centers, with a total of more than 4.948 million patients. Infant screening services are provided to promote early detection, early diagnosis and early intervention of genetic metabolic diseases.
In the next step, the Shanghai Municipal Health Commission will continue to improve the city’s newborn genetic metabolic disease screening service system, continue to standardize the screening work process, strengthen quality control, improve service levels, and continue to optimize early detection, early diagnosis, and early intervention. mechanism.
![Starting from tomorrow, the screening of newborn genetic metabolic diseases in Shanghai will increase from 4 to 15 types.](https://a5qu.com/upload/images/2cfcd5c6b85bf6dfe4004a20dd57b173.webp)
![](https://a5qu.com/s/user/default.webp)